Okta Inc. (OKTA)

The price of $178.36 sits below both the 20-day EMA of $194.80 and the 50-day SMA of $197.14, yet remains well above the 200-day SMA of $127.65, so the trend is mixed rather than broken. The stock is 24.10% below its 52-week high of $235.00, and the question for holders is whether the business can keep growing earnings while the valuation, at a trailing P/E of 107.45, leaves little room for disappointment.

Okta has beaten EPS estimates in all eight recent reports. The August 26, 2026 report delivered adjusted EPS of $1.05 against an estimate of $0.96, a beat of 9.38%, and the stock rose 28.63% in the first session after it. The May 28, 2026 report also beat, with EPS of $0.91 against $0.85, and the stock rose 30.14% the next session. The record is strong, though the market has not always rewarded each beat: one of the eight beats was followed by a lower share price in the first session.

At a trailing P/E of 107.45, Okta trades at a premium to peers, and that figure is 206.1% above the sector median of 35.1. The price-to-sales ratio of 10.21 is also 34.3% above the sector median of 7.6. Revenue grew 10.60% in the latest quarter, year on year, against a sector median of 24.2%, so the company is growing more slowly than most of its peers while carrying a richer price.

The stock fell 5.97% in the past week and 23.16% over the past month, even though it is up 125.60% over six months. The price sits 9.53% below its 50-day SMA and 8.44% below its 20-day EMA, while it remains 39.72% above its 200-day SMA. The 50-day SMA is 54.44% above the 200-day SMA, which shows the longer-term trend is still rising. The 14-day RSI is 40.8, in the neutral zone, and the MACD line is negative, so short-term momentum has weakened.

Of 44 analysts with a current rating, 34 rate the stock buy or strong buy, 10 hold, and none sell. Three months ago, 33 of 44 rated it buy. Citigroup kept its Neutral rating on October 15, 2026, BMO Capital kept its Outperform rating on October 9, 2026, and Amerx started coverage at Hold on October 8, 2026. Over the last 18 months, insiders sold $68.4M of stock across 40 sales and bought $267K in one open-market purchase. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than open-market buying.

The base case is that Okta trades in a wide range while investors weigh strong earnings against slowing sales. The company has beaten EPS estimates in all eight recent reports, and analysts expect EPS to grow 12.3% this fiscal year and revenue to grow 10.4%. Revenue growth of 10.60% in the latest quarter, however, trails the sector median of 24.2%, and that gap is the main reason the valuation looks stretched. A recovery toward the 50-day SMA would need the price to clear $197.14 on steady volume. A failure to hold above the 200-day SMA of $127.65 would signal that the longer uptrend is weakening. Analysts' median 12-month target is $225.00, with a range from $127.00 to $250.00. These are analysts' forecasts, not guarantees, and the stock's typical daily move of 4.66% means large swings remain normal.

Support sits first at $127.65, the 200-day simple moving average, which the price has stayed well above. Below that is the 52-week low of $62.66, a far-off floor that marks the bottom of the past year's range. Resistance comes first at the 20-day exponential moving average of $194.80, then the 50-day simple moving average of $197.14, which the price has recently fallen below. Above those sits the 52-week high of $235.00, the level the stock would need to reach to erase the recent decline.